Skip to main content
Log in

Concentrations of ceftazidime, tobramycin and ampicillin in the cerebrospinal fluid of newborn infants

  • Pharmacology
  • Original Papers
  • Published:
European Journal of Pediatrics Aims and scope Submit manuscript

Abstract

Thirty-five neonates with suspected septicaemia were randomized to treatment with tobramycin or ceftazidime, both in combination with ampicillin. Concentrations of antibiotics in the CSF were measured 1 h after the third, fourth or fifth injection. In 13 of 17 neonates tobramycin CSF concentrations were below 0.5 mg/l. Ceftazidime CSF concentrations ranged from 2.5 to 17 mg/l, which should be sufficient for treatment of infections with group B streptococci and most aerobic gram-negative bacilli but not all strains of Staphylococcus aureus. Ampicillin CSF concentrations ranged from 1 to 80 mg/l, which should be sufficient for treatment of meningitis caused by enterococci and Listeria monocytogenes, the most important neonatal pathogens not covered by ceftazidime.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Blumer JL, Aronoff SC, Myers CM, O'Brien CA, Klinger JD, Reed MD (1985) Pharmacokinetics and cerebrospinal fluid penetration of ceftazidime in children with meningitis. Dev Pharmacol Ther 8:219–231

    Google Scholar 

  2. Fong IW, Tomkins KB (1984) Penetration of ceftazidime into the cerebrospinal fluid with and without evidence of meningeal inflammation. Antimicrob Agents Chemother 26:115–116

    Google Scholar 

  3. Geering JM, Just M (1975) Die Blut-Liquor Verteilung von Ampicillin bei Kindern mit und ohne seröse Meningitis. Monatsschr Kinderheilkd 123:545–547

    Google Scholar 

  4. Hatch D, Overtyrf GD, Kovacs A, Forthal D, Leong C (1986) Treatment of bacterial meningitis with ceftazidime. Pediatr Infect Dis 5:416–420

    Google Scholar 

  5. Jalling B, Malmborg AS, Boréus LO (1972) Evaluation of a micromethod for determination of antibiotic concentration in plasma. Eur J Clin Pharmacol 4:150–157

    Google Scholar 

  6. Jones RN, Barry AL, Thornsberry C, Gerlach EH, Fuchs PC, Gavan TL, Sommers HM (1981) Ceftazidime, a pseudomonasactive cephalosporin: in vitro antimicrobial evaluation including recommendations for disc diffusion susceptibility tests. J Antimicrob Chemother 8 [Suppl B]:187–211

    Google Scholar 

  7. Kaiser AB, McSee ZA (1975) Aminoglycoside therapy of Gramnegative bacillary meningitis. N Engl J Med 293:1 1215–1220

    Google Scholar 

  8. Low DC, Bisseden JG, Wise R (1985) Ceftazidime in neonatal infections. Arch Dis Child 60:360–364

    Google Scholar 

  9. McCracken GH (1972) The rate of bacteriologic response to anti-microbial therapy in neonatal meningitis. Am J Dis Child 123: 547–553

    Google Scholar 

  10. Modai J, Vittecoq D, Decazes JH, Wolff M, Meulemans A (1983) Penetration of ceftazidime into cerebrospinal fluid of patients with bacterial meningitis. Antimicrob Agents Chemother 24:126–128

    Google Scholar 

  11. Moellering RS, Fisher EG (1972) Relationship of intraventricular gentamicin levels to cure of meningitis. J Pediatr 81:534–537

    Google Scholar 

  12. Mullhall A, Louvois J de, Hurley R (1983) Incidence of potentially toxic concentration of gntamicin in neonates. Arch Dis Child 58:897–900

    Google Scholar 

  13. Neu HC (1981) In vitro activity of ceftazidime, a betalactamase stable cephalosporin. J Antimicrob Chemother 8 [Suppl B]:131–134

    Google Scholar 

  14. Norrby R (1978) A review of the penetration of antibiotics into CSF and its clinical significance. Scand J Infect Dis [Suppl] 14: 296–309

    Google Scholar 

  15. Phillips I, Warren C, Shannon K, King A, Hanslo D (1981) Ceftazidime: in vitro antibacterial activity and susceptibility to beta-lactamases compared with that of cefotaxime, moxalactam and other beta-lactam antibiotics. J Antimicrob Chemother 8 [Suppl B]:25–31

    Google Scholar 

  16. Rodriguez WJ, Puig JR, Khan WH, Feris J, Gold BG, Sturla C (1986) Ceftazidime vs standard therapy for pediatric meningitis: therapeutic, pharmacologic and epidemiologic observations. Pediatr Infect Dis 5:408–415

    Google Scholar 

  17. Statz A, Feigenhauer K (1983) Development of the blood-CSF barrier. Develop Med Child Neurol 25:152–161

    Google Scholar 

  18. Taber LH, Yow MD, Nieberg FG (1967) The penetration of broad spectrum antibiotics into the cerebrospinal fluid. Ann NY Acad Sci 145:473–481

    Google Scholar 

  19. Tessin I, Thiringer K, Trollfors B, Brorson J-E (1988) Comparison of serum concentrations of ceftazidime and tobramycin in newborn infants. Eur J Pediatr 147:405–407

    Google Scholar 

  20. Thrupp Ld, Leedom JM, Ivler D, Wehrle PF, Portnoy B, Matthies AW (1966) Ampicillin levels in cerebrospinal fluid during treatment of bacterial meningitis. Antimicrob Agents Chemother, pp 206–213

  21. Tuazon CU, Shamsuddin D, Miller A (1982) Antibiotic susceptibility and synergy of clinical isolates of Listeria monocytogenes. Antimicrob Agents Chemother 21:525–527

    Google Scholar 

  22. Wilkinson ID, Gentry LO (1981) In vitro comparison of ceftazidime and nine other antimicrobial agents against hospital strains of Gram-negative bacteria. J Antimicrob Chemother 8 [Suppl B]: 53–56

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tessin, I., Trollfors, B., Thiringer, K. et al. Concentrations of ceftazidime, tobramycin and ampicillin in the cerebrospinal fluid of newborn infants. Eur J Pediatr 148, 679–681 (1989). https://doi.org/10.1007/BF00441533

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00441533

Keywords

Navigation